The most common adverse events of grade @ or @ were neutropenia ( @ -LSB- @ % -RSB- in the etoposide plus cisplatin group vs @ -LSB- @ % -RSB- in the irinotecan plus cisplatin group ) , anaemia ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) , thrombocytopenia ( @ -LSB- @ % -RSB- vs six -LSB- @ % -RSB- ) , febrile neutropenia ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) , and diarrhoea ( two -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) .